Middle East and Africa Cardiovascular Devices Market
The rapidly increasing prevalence of Cardiovascular Devices is raising the demand for technically advanced devices for diagnosing and treating patients with effective and efficient care. The market for the mitral valve is likely to experience continuous developments in mitral valve repair and percutaneous mitral valve replacement procedures. In October 2020, Medtronic launched the Azure pacemaker with BlueSync technology—it is India's first and only pacemaker capable of establishing communications directly with patients' cellphones and tablets. For instance, NewPace Ltd. (Israel) has developed implantable string subcutaneous defibrillators (ISSD) with the help of researchers at Na Homolce Hospital in Prague, Czech Republic. ISSD is a less invasive device that can prevent sudden deaths caused by cardiac conditions. The device does not require a metal pulse generator pocket. ISSD takes 20 minutes for implantation, and it can be connected to a smartphone. Thus, such advanced devices are
likely to lead to new trends in the MEA cardiovascular devices market in the future. The Middle East & Africa Cardiovascular Devices market is expected to grow at a good CAGR during the forecast period.
Middle East & Africa Cardiovascular Devices Market Segmentation
The Middle East & Africa cardiovascular devices market is segmented into device, application, end user, and country. Based on device, the market is segmented into electrocardiography (ECG), pacemaker, stent, defibrillator, cardiac catheter, guidewire, heart valve, event monitor, and others. The event monitor segment dominated the market in 2020. In terms of application, the market is segmented into coronary heart disease, sudden cardiac arrest, stroke, cerebrovascular heart disease, and others. The coronary heart disease segment dominated the market in 2020. Based on end user, the market is segmented into hospitals, ambulatory surgery centers, and cardiac centers. The hospitals segment dominated the market in 2020. Based on country, the Middle East & Africa cardiovascular devices market is segmented into Saudi Arabia, UAE, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa cardiovascular devices market in 2020.
Medtronic, Boston Scientific Corporation, Abbott, Johnson and Johnson Service Inc, General Electric Company, Koninklijke Philips N.V, Siemens Healthineers AG, BD, B. Braun Melsungen AG, and Edwards Lifesciences Corporation are among the leading companies in the Middle East & Africa cardiovascular devices market.
The Middle East and Africa Cardiovascular Devices Market is valued at US$ 3,184.65 Million in 2021, it is projected to reach US$ 4,867.10 Million by 2028.
As per our report Middle East and Africa Cardiovascular Devices Market, the market size is valued at US$ 3,184.65 Million in 2021, projecting it to reach US$ 4,867.10 Million by 2028. This translates to a CAGR of approximately 6.2% during the forecast period.
The Middle East and Africa Cardiovascular Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Cardiovascular Devices Market report:
The Middle East and Africa Cardiovascular Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Cardiovascular Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Cardiovascular Devices Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Cardiovascular Devices Market
